Lynn Seely, M.D.

Lynn Seely, M.D.

President, Chief Executive Officer and DirectoratLyell Immunopharma· In proxies 2021–2025

Pay in FY2025+182% from the year before · Lyell Immunopharma stock +140.5% the same year

Lynn Seely, M.D. was paid $4.2M in FY2025 (Dec), up 182%. Lyell Immunopharma stock rose 140.5% that year.

Pay$100 in the stock at the end of FY21 → $20
Pay is from the Summary Compensation Table of each Lyell Immunopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lyell ImmunopharmaPublic company · 5 yr
    • President, Chief Executive Officer and Director2021 – Present · 5 yrStock in role -97%
  2. Managers for LifePublic company
    • Director? – PresentNo stock prices for these years
  3. Managers for Life Science Cares Bay AreaPublic company
    • Director? – PresentNo stock prices for these years
  4. Blueprint Medicines CorporationPublic company · 10 yr
    • Director2016 – Present · 10 yrNo stock prices for these years
  5. TORL Biotherapeutics CorporationPublic company · 2 yr
    • Director2023 – 2025 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?